Your browser doesn't support javascript.
loading
Elucidation of the statistical factors that influence anti-drug antibody cut point setting through a multi-laboratory study.
Nishimura, Kazuko; Shibata, Hiroko; Aoyama, Muneo; Hosogi, Jun; Kadotsuji, Kenta; Minoura, Kyoko; Mori, Tamiki; Nakamura, Takahiro; Nishimiya, Kazuhiro; Nomura, Tatsuki; Saito, Tetsu; Soma, Masako; Wakabayashi, Hiroki; Sakamoto, Norihisa; Niimi, Shingo; Katori, Noriko; Saito, Yoshiro; Ishii-Watabe, Akiko.
Afiliación
  • Nishimura K; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
  • Shibata H; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
  • Aoyama M; Eisai Co., Ltd, 5-1-3 Tokodai, Tsukuba-shi, Ibaraki 300-2635, Japan.
  • Hosogi J; Kyowa Hakko Kirin Co., Ltd, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8731, Japan.
  • Kadotsuji K; Sumitomo Dainippon Pharma Co., Ltd, 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-0022, Japan.
  • Minoura K; Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
  • Mori T; LSI Medience Corporation, 3-30-1 Shimura, Itabashi-ku, Tokyo 174-8555, Japan.
  • Nakamura T; Shin Nippon Biomedical Laboratories, Ltd, 16-1 Minami-Akasaka, Kainan, Wakayama 642-0017, Japan.
  • Nishimiya K; Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura-shi, Kanagawa 247-8530, Japan.
  • Nomura T; Shin Nippon Biomedical Laboratories, Ltd, 16-1 Minami-Akasaka, Kainan, Wakayama 642-0017, Japan.
  • Saito T; Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan.
  • Soma M; Daiichi Sankyo Co., Ltd, 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan.
  • Wakabayashi H; LSI Medience Corporation, 3-30-1 Shimura, Itabashi-ku, Tokyo 174-8555, Japan.
  • Sakamoto N; Tachikawa Chuo Hospital, 2-17-14 Shibasaki-cho, Tachikawa-shi, Tokyo 190-0023, Japan.
  • Niimi S; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
  • Katori N; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
  • Saito Y; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
  • Ishii-Watabe A; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
Bioanalysis ; 11(6): 509-524, 2019 Mar.
Article en En | MEDLINE | ID: mdl-30945932
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Productos Biológicos / Inmunoensayo / Bases de Datos Farmacéuticas / Anticuerpos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Bioanalysis Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Productos Biológicos / Inmunoensayo / Bases de Datos Farmacéuticas / Anticuerpos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Bioanalysis Año: 2019 Tipo del documento: Article